Indicated for: leishmaniasis
Route of administration: oral
Substance: miltefosine (antiprotozoal)
ATC: P01CX04 (Antiparasitic products, insecticides and repellents | Agents against leishmaniasis and trypanosomiasis | Other agents against leishmaniasis and trypanosomiasis)
Miltefosine is an antiprotozoal agent used for the treatment of visceral and cutaneous leishmaniasis. It works by disrupting the cell membranes of the parasite, leading to its death.
The medication is taken orally, usually once or twice daily, with the duration of treatment varying based on the type and severity of the infection. Common side effects include nausea, vomiting, diarrhea, and abdominal pain.
Miltefosine is contraindicated in pregnant and breastfeeding women, as well as in patients with hypersensitivity to the active substance. Its use also requires careful monitoring to prevent renal and hepatic toxicity.
This medication is an important option for the treatment of leishmaniasis, helping to reduce mortality and alleviate symptoms.